Evidence map›Paper›PMID 27066467›Full record

ReviewFrontiers in public health2016

Key Considerations for an Economic and Legal Framework Facilitating Medical Travel.

Saba Hinrichs-Krapels, Sarah Bussmann, Christopher Dobyns, Ondřej Kácha, Nora Ratzmann, Julie Holm Thorvaldsen, Kai Ruggeri

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saba Hinrichs-KrapelsThe Policy Institute, King's College London , London , UK.
Sarah BussmannDepartment of Psychology, University of Cambridge , Cambridge , UK.
Christopher DobynsDepartment of Politics and International Relations, University of Oxford , Oxford , UK.
Ondřej KáchaDepartment of Psychology, Faculty of Arts, Masaryk University , Brno , Czech Republic.
Nora RatzmannDepartment of Social Policy, London School of Economics , London , UK.
Julie Holm ThorvaldsenDepartment of Psychology, Norwegian University of Science and Technology , Trondheim , Norway.
Kai RuggeriPolicy Research Group, Department of Psychology, University of Cambridge, Cambridge, UK; Engineering Design Centre, Department of Engineering, University of Cambridge, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical travel has the capacity to counter increasing costs of health care by creating new markets and increased revenue for health services, potentially benefiting local populations, economies, and health-care systems. This paper is part of a broad, comprehensive project aimed at developing a global health access policy (GHAP). It presents key issues to consider in terms of ensuring economic viability, sustainability, and limiting risk to the many stakeholders involved in the rapidly expanding industry of medical travel. The noted economic and legal barriers to medical travel are based on a synthesis of themes found in an extensive review of the available literature. Economic considerations, when setting up a GHAP, include a dynamic approach to pricing that is fair to the local population. Legal considerations include the implementation of international quality standards and the protection of the rights of those traveling as well as those of local populations in recipient countries. By taking into account these opportunities, the GHAP will more adequately address existing gaps in the economic and legal regulation of medical travel.

Indexed as

adverse effectseconomic and legal frameworkmedical travelmedical travel processpublic policy

Identifiers

PMID27066467
PMCPMC4814659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.